

Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|11|9|1030-1043
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.11, Iss.9, 2011-11, pp. : 1030-1043
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Non-Hodgkin's Lymphoma in the Elderly
By Caimi Paolo F. Barr Paul M. Berger Nathan A. Lazarus Hillard M.
Drugs & Aging, Vol. 27, Iss. 3, 2010-03 ,pp. :


By Rule Simon
Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. :


Chemokines and antagonists in non-Hodgkin's lymphoma
By Golay Josée Introna Martino
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. :


QOL in non-Hodgkin's and Hodgkins lymphoma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. :